FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Teva Pharmaceuticals Acarbose Tablets Recall

Acarbose Tablets, 25 mg, 100-count bottle, Rx only, Manufactured by: Arrow Pharm (Malta…

Teva Pharmaceuticals USA · North Wales, PA

Risk level
Class II
Reported by FDA
Oct 4, 2017
Recall ID
D-1178-2017
Check your lot numberHow we source this data

Summary

Teva Pharmaceuticals recalled Acarbose Tablets starting Sep 5, 2017. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1178-2017 on Oct 4, 2017. Reason: Labeling: Incorrect or Missing Lot and/or Exp Date: An incorrect expiration date of July 2018 is printed on the product labeling rather than the correct expiration date of July 2017. Status: Terminated.

Why it was recalled

Labeling: Incorrect or Missing Lot and/or Exp Date: An incorrect expiration date of July 2018 is printed on the product labeling rather than the correct expiration date of July 2017.

Product description

Acarbose Tablets, 25 mg, 100-count bottle, Rx only, Manufactured by: Arrow Pharm (Malta) Ltd., Birzebbugia BBG3000, Malta; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054; NDC 16252-523-01.

Lot numbers, UPCs & expiration codes

Lot #: 1082710A, Exp 07/18

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1178-2017
Classification
Class II
Status
Terminated
Recall initiated
Sep 5, 2017
FDA report date
Oct 4, 2017
Quantity
3,275 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Teva Pharmaceuticals USA

Original FDA data

Every field from FDA enforcement report D-1178-2017, exactly as published.

Show all FDA fields
City
North Wales
State
PA
Status
Terminated
Country
United States
Event ID
78060
Address
1090 Horsham Rd
Code information
Lot #: 1082710A, Exp 07/18
Postal code
19454-1505
Report date
Oct 4, 2017
Product type
Drugs
Recall number
D-1178-2017
Classification
Class II
Recalling firm
Teva Pharmaceuticals USA
Product quantity
3,275 bottles
Termination date
Jun 21, 2018
Reason for recall
Labeling: Incorrect or Missing Lot and/or Exp Date: An incorrect expiration date of July 2018 is printed on the product labeling rather than the correct expiration date of July 2017.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Acarbose Tablets, 25 mg, 100-count bottle, Rx only, Manufactured by: Arrow Pharm (Malta) Ltd., Birzebbugia BBG3000, Malta; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054; NDC 16252-523-01.
Distribution pattern
Nationwide in the USA
Recall initiation date
Sep 5, 2017
Initial firm notification
Letter
Center classification date
Sep 28, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1178-2017, published Oct 4, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls